FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Gemcitabine Hydrochloride Injection
Status: Discontinuation
»Therapeutic Categories: Oncology

Expand all

Apotex Corp. (New 01/08/2020)

Company Contact Information:
800-706-5575

Presentation Posting Date Related Information
200 mg/5.26 mL (38 mg/mL), single dose vial (NDC 60505-6113-6) 01/08/2020 Apotex made a business decision to discontinue this product.
1 g/26.3 mL (38 mg/mL), single dose vial (NDC 60505-6114-0) 01/08/2020 Apotex made a business decision to discontinue this product.
2 g/52.6 mL (38 mg/mL), single dose vial (NDC 60505-6115-2) 01/08/2020 Apotex made a business decision to discontinue this product.

Mylan (New 12/16/2019)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
1 g, single dose vial (NDC 67457-462-01) 12/16/2019 Expected Discontinuation March/April 2020

Teva Pharmaceuticals (New 01/16/2020)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
200 mg, single dose vial (NDC 45963-612-57) 01/07/2020
2 g, single dose vial (NDC 45963-620-60) 01/07/2020
1 g, single dose vial (NDC 45963-619-59) 01/16/2020 Actively selling; Remaining inventory estimated to last through April 2020
200 mg/5.26 mL (38 mg/mL), single dose vial (NDC 45963-623-57) 01/16/2020 Actively selling; Remaining inventory estimated to last through March 2020
1 g/26.3 mL (38 mg/mL), single dose vial (NDC 45963-624-58) 01/16/2020 Actively selling; Remaining inventory estimated to last through July 2020
2 g/52.6 mL (38 mg/mL), single dose vial (NDC 45963-636-60) 01/16/2020 Actively selling; Remaining inventory estimated to last through March 2020

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English